Conference Focus

By attending this conference, attendees will be involved in discussions of innovations in pre-clinical studies, clinical trial designs, biomarker discoveries and target identification for therapeutic and drug discovery journey. Attendees will gain valuable industry leaders’ perspective and conduct benchmarking with peers on the latest developments in drug discovery for neurodegenerative diseases. The challenges faced in today’s neurodegenerative drug discovery process are big, but significant advances have taken place and the race is on to find the next blockbuster therapy. Significant progress has been made to understand these fatal and chronic diseases. Industry leaders will gain much in a stimulating, informative and up-to-date meeting of like minds. Attendees will learn from the best minds on ways to tackle one of humankind’s more pressing health issues.

Key Topics

• Regeneration in NDD through Neurogenesis
• Revolutionizing Drug Discovery & Rehabilitation Medicine by Applying Robotics and Information Technology
• Neuroimaging Biomarker Developments
• Hormesis Applications for Neurodegenerative Diseases
• Allosteric Modulation of Gamma-Secretase Reduces Beta-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease